How to Approach Immune Checkpoint Inhibitor Enterocolitis.
作者信息
Wang Yinghong Mimi
机构信息
Department of Gastroenterology, Hepatology & Nutrition Professor on Tenure Track Director of Oncology-GI Toxicity Program Director of Fecal Microbiota Transplantation Chair of MD Anderson Cancer Center Immunotherapy Toxicity Working Group The University of Texas MD Anderson Cancer Center Houston, Texas.
出版信息
Gastroenterol Hepatol (N Y). 2025 Aug;21(8):501-503.
Abstract
摘要
相似文献
1
How to Approach Immune Checkpoint Inhibitor Enterocolitis.如何应对免疫检查点抑制剂相关性小肠结肠炎
Gastroenterol Hepatol (N Y). 2025 Aug;21(8):501-503.
2
Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis.系统评价与荟萃分析：抗炎治疗在免疫检查点抑制剂诱导的肠炎中的疗效。
Aliment Pharmacol Ther. 2020 Nov;52(9):1432-1452. doi: 10.1111/apt.15998. Epub 2020 Sep 13.
3
[Clinical and Ultrasound Manifestations of Immune Checkpoint Inhibitor-Associated Enterocolitis:Report of One Case].
Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2025 Aug 4. doi: 10.3881/j.issn.1000-503X.16799.
4
Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.基于炎症性肠病治疗的免疫检查点抑制剂相关性肠炎的管理考虑
Inflamm Bowel Dis. 2020 Apr 11;26(5):662-668. doi: 10.1093/ibd/izz212.
5
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.免疫检查点抑制剂相关性肠炎的预防和治疗的药理学干预：系统评价。
Dig Dis Sci. 2022 Apr;67(4):1128-1155. doi: 10.1007/s10620-021-06948-w. Epub 2021 Mar 26.
6
Evaluation of appendectomy as a potential risk factor for immune checkpoint inhibitor-associated enterocolitis.评估阑尾切除术是否为免疫检查点抑制剂相关性肠炎的潜在危险因素。
Immunotherapy. 2023 Aug;15(12):913-920. doi: 10.2217/imt-2022-0245. Epub 2023 Jun 9.
7
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.免疫检查点抑制剂相关性肠炎与特发性炎症性肠病。
Clin Gastroenterol Hepatol. 2023 Apr;21(4):878-890. doi: 10.1016/j.cgh.2022.10.004. Epub 2022 Oct 18.
8
Enterocolitis due to immune checkpoint inhibitors: a systematic review.免疫检查点抑制剂相关性肠炎：系统评价。
Gut. 2018 Nov;67(11):2056-2067. doi: 10.1136/gutjnl-2018-316948. Epub 2018 Aug 21.
9
Prognostic Value of Inflammatory Bowel Disease-associated Biomarkers in Patients With Immune Checkpoint Inhibitor Enterocolitis: A Retrospective Cohort Study.
Inflamm Bowel Dis. 2024 Jun 3;30(6):1032-1035. doi: 10.1093/ibd/izad121.
10
Immune checkpoint inhibitor gastritis is often associated with concomitant enterocolitis, which impacts the clinical course.免疫检查点抑制剂性胃炎常伴有小肠结肠炎，这会影响临床病程。
Cancer. 2023 Feb 1;129(3):367-375. doi: 10.1002/cncr.34543. Epub 2022 Nov 14.
本文引用的文献
1
Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.免疫相关肠炎患者的免疫检查点抑制和选择性免疫抑制治疗的联合应用。
J Immunother Cancer. 2023 Jun;11(6). doi: 10.1136/jitc-2023-007195.
2
Immune Checkpoint Inhibitor Enterocolitis vs Idiopathic Inflammatory Bowel Disease.免疫检查点抑制剂相关性肠炎与特发性炎症性肠病。
Clin Gastroenterol Hepatol. 2023 Apr;21(4):878-890. doi: 10.1016/j.cgh.2022.10.004. Epub 2022 Oct 18.
3
Pharmacological Interventions for the Prevention and Treatment of Immune Checkpoint Inhibitor-Associated Enterocolitis: A Systematic Review.免疫检查点抑制剂相关性肠炎的预防和治疗的药理学干预：系统评价。
Dig Dis Sci. 2022 Apr;67(4):1128-1155. doi: 10.1007/s10620-021-06948-w. Epub 2021 Mar 26.
4
AGA Clinical Practice Update on Diagnosis and Management of Immune Checkpoint Inhibitor Colitis and Hepatitis: Expert Review.AGA 临床实践更新：免疫检查点抑制剂相关性结肠炎和肝炎的诊断与管理：专家综述。
Gastroenterology. 2021 Mar;160(4):1384-1393. doi: 10.1053/j.gastro.2020.08.063. Epub 2020 Oct 17.
5
Systematic review with meta-analysis: effectiveness of anti-inflammatory therapy in immune checkpoint inhibitor-induced enterocolitis.系统评价与荟萃分析：抗炎治疗在免疫检查点抑制剂诱导的肠炎中的疗效。
Aliment Pharmacol Ther. 2020 Nov;52(9):1432-1452. doi: 10.1111/apt.15998. Epub 2020 Sep 13.
6
Gut Microbiome and Immune Checkpoint Inhibitor-Induced Enterocolitis.肠道微生物组与免疫检查点抑制剂相关性肠炎
Dig Dis Sci. 2020 Mar;65(3):797-799. doi: 10.1007/s10620-020-06103-x.
7
Management Considerations for Immune Checkpoint Inhibitor-Induced Enterocolitis Based on Management of Inflammatory Bowel Disease.基于炎症性肠病治疗的免疫检查点抑制剂相关性肠炎的管理考虑
Inflamm Bowel Dis. 2020 Apr 11;26(5):662-668. doi: 10.1093/ibd/izz212.
Zotero 插件